CASP4 and non-small cell lung carcinoma: Moreover, 33.78% of tissue-caspase-4 positive NSCLC patients (25 out of 74) were LDH negative (Figure 1D, red bar on the right) (Table 1), implying that in the tumor mass, differently than what observed in the blood, a differential metabolic pattern can exist.